About
Dr. Rienhoff is a physician, entrepreneur and founder of several biotech and presently serves as CEO of Imago BioSciences. Dr. Rienhoff was the founder and CEO of FerroKin Biosciences, a development stage company that was acquired by Shire in for $325 million in 2012. He has more than 20 years experience as both a venture investor and entrepreneur in the life science sector. He was a partner at New Enterprise Associates and later, a director of Abingworth Management Ltd., running their US operation. Dr. Rienhoff is an Adjunct Scientist at the Children's Hospital Oakland Research Institute. He received his M.D. from the Johns Hopkins University School of Medicine and his B.A. from Williams College.
Position in the VCSift Database
- • 1,349 investors hold the Founder and CEO role in VCSift. Hugh Rienhoff is one of them.
- • 7,285 investors are based in San Francisco, California, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- San Francisco, US
Contact Information
Find more investors like Hugh
Search Investors